Summary To compare the relative heat sensitivities of human normal and neoplastic cells of the same tissue type, a study was carried out of the relative sensitivities to heat of granulocyte/macrophage progenitor cells (CFU-GM) derived from the peripheral blood and bone marrow of normal subjects and patients with chronic granulocytic leukaemia (CGL). Nucleated haemopoietic cells were incubated at temperatures in the range 41.5°C to 44.0°C for various periods before culture in agar. The results of these experiments showed that CFU-GM from normal blood were consistently less sensitive to damage by heat than normal marrow CFU-GM. There was no comparable difference in the relative heat sensitivities of CFU-GM from blood and marrow of patients with CGL and no significant difference between the heat sensitivities of CFU-GM derived from marrow from normal individuals and patients with CGL. The observed difference in heat sensitivity of CFU-GM from normal blood and marrow accords with other data suggesting that the two progenitor cell compartments are distinct: the blood CFU-GM may represent a more primitive population of committed progenitor cells. In CGL, CFU-GM in the blood may much more closely resemble those in the marrow. The data provide no support for the hypothesis that malignant cells differ intrinsically from their normal counterparts in respect of sensitivity to damage by hyperthermia.
Computation of survival curve parameters In order to quantify the CFU-GM survival, the data resulting from heat treatment at each fixed temperature, for various lengths of time, were fitted to a "multitarget function" of the form
where S is the fraction of CFU-GM surviving (i.e. ratio of mean number of colonies in heated/control groups), D is the treatment time at the temperature concerned (acting as a measure of the "dose" given) and Do and n are the survival curve parameters to be estimated.
The function was used since, although some curves showed evidence of "continuing curvature", the majority appeared to be of the type having an initial "shoulder" followed by an exponential portion. 
Results
The results are shown in Figures 1-3 and in Table  I . Figure 1 shows the effects of heating at various temperatures on survival of CFU-GM derived from peripheral blood of normal subjects (Figure la) or CGL patients (Figure lb) . Figure 2 provides an example at a single temperature, 42.5°C, of the survival of CFU-GM derived from either blood or marrow of normal subjects and from either blood or marrow of CGL patients. The origin of the apparent differences in heat sensitivity between normal blood CFU-GM and other groups is not clear. It is tempting to speculate, however, that this effect could result from some difference in the nature of CFU-GM present in the blood as compared to the marrow of normal individuals, this difference being lost in CGL. There is evidence that, in the case of normal subjects, CFU-GM derived from peripheral blood differ from CFU-GM derived from marrow. For example, blood-derived CFU-GM give rise to many more eosinophilic colonies than do bone marrow CFU-GM (Verma et al., 1980) ; they also differ in sedimentation velocity and in the proportion of cells which are cycling under steady-state conditions (Tebbi et al., 1976 ). These observations suggest that (Goldman et al., 1974) ; whether it is correct in this case remains speculative. If the heat sensitivity of blood CFU-GM dose differ from that of marrow CFU-GM, at least in normal individuals, it would be important to ensure that the lesser sensitivity of the more accessible blood CFU-GM were not taken as representative of the sensitivity of marrow CFU-GM, e.g. in assessing haemopoietic tolerance to total body hyperthermia. Such considerations could be particularly important if hyperthermia were to be combined with myelosuppressive drugs, a combination which may, in any case, result in unfavourable therapeutic differentials (Honess & Bleehen, 1982) .
Of the available data, only those for normal blood CFU-GM were deemed to be sufficiently extensive to warrant Arrhenius analysis to determine the activation energy of the lethal process. The resultant Arrhenius plot (Figure 3) shows a transition at about 42.5°C. Below this "break point", the Activation Energy is calculated to be 1756kJmole-1°C-1, but is 928kJmole-1C-1 above this point. These activation energy values correspond to an increase of heating time per 1C0 temperature change (to maintain iso-effective cell survival) by a factor of 5.4 at temperatures below the transition point, falling to a factor of 2.8 at temperatures above it. This may be compared with a factor of 6 at temperatures below transition, and a factor of 2 at temperatures above it which have been proposed by Field & Morris (1983) as typical for a variety of cells and tissues, based on an extensive review. The implication of the present findings is that the transition is, in the case of CFU-GM, broadly similar to, but rather less sharp than, the corresponsing transition for other cells and tissues. These results are similar to values deduced from data recently published by Bromer et al. (1982) on the heat sensitivity of CFU-GM derived from human bone marrow. They differ, however, from those reported by Elkon & McGrath (1981) Symonds et al. (1981 Symonds et al. ( , 1984 on the heat sensitivity of normal "stem cells" (CFU-S) and leukaemic clonogenic cells in the DBA2 mouse. Symonds et al. (1981) found mouse haemopoietic cells (both normal and leukaemic) to be very sensitive to heat; considerably more so than appears to be the case for human CFU-GM, as evidenced by the present findings and those of Bromer et al. (1982) or for mouse CFU-D as reported by Elkon & McGrath (1981) . In addition, Symonds et al. (1981) observed a significant difference in the heat sensitivities of normal and leukaemic cells derived from bone marrow. However, the activation energies for normal and leukaemic cells were similar, approximately 945 kJ mole -C-1 with no evidence of a "break point" within the temperature range 42°C-440C. The absolute heat sensitivities were found to be strongly influenced by nutritional milieu (Symonds et al., 1984) .
If, as seems possible, differences of cell position within a hierarchical lineage (e.g. CFU-S versus CFU-D or CFU-GM), species differences, different assay conditions and nutritional milieu effects all contribute to the observed differences in heat sensitivity, then extensive investigations may be necessary to determine the hyperthermia sensitivities of different cell lineages of the In conclusion:
(1) The heat sensitivity of CFU-GM derived from normal human blood, was, for all temperatures within the range 41.50C-44.00C, consistently less than that of CFU-GM derived from normal bone marrow, and less than those of CFU-GM derived from either blood or marrow of CGL patients.
(2) The heat sensitivity of normal marrow CFU-GM was not consistently different from that of CGL CFU-GM, wherether derived from blood or marrow. Hence, there was no clear-cut evidence for an intrinsic increase in heat sensitivity conferred by malignant transformation, at least in CGL.
(3) The relative heat resistance of normal blood CFU-GM might reflect a maturational or kinetic difference in CFU-GM derived from blood from that of marrow of normal individuals. In CGL it is possible that these differences are abolished because "marrow type" CFU-GM circulate in blood.
(4) Arrhenius analysis was possible only for normal blood CFU-GM. For this case, the activation energy for heat killing of CFU-GM was 1756 kJ mole-1 aC-1 at temperatures below 42.5°C and 928 kJ mole -1 C-1 at temperatures above it.
